Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 444 (RNA5SP444) is an annotated processed pseudogene in the human genome, originating from a retrotransposed copy of the 5S ribosomal RNA gene. While functional 5S rRNA is a key component of the large ribosomal subunit and plays essential roles in protein synthesis, pseudogenes like RNA5SP444 have lost their protein-coding capacity due to mutations and lack conventional promoter elements. Processed pseudogenes typically integrate at new genomic locations, may contain a poly(A) tail, and do not encode functional RNA or protein products. Although some pseudogenes can exert regulatory effects by acting as miRNA sponges or through antisense interactions, there is currently no evidence that RNA5SP444 has such functions or clinical relevance[2][3][4]. As a processed rRNA pseudogene, it is not considered a receptor, enzyme, or any other therapeutic target. Its inclusion in target lists or drug discovery pipelines is incorrect[3][4].
None. There are no drugs or therapeutic mechanisms related to this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 444 (RNA5SP444).